Submit Deal

BEACON THERAPEUTICS LIMITED

HQ - Alachua

Summary

Beacon Therapeutics is a gene therapy company dedicated to developing treatments for blinding retinal diseases.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 286 M

Avg. Deal Size£ 95 M

Market Context

Senior Management

Senior Management

Sort

beacon therapeutics limited

HQ - United States

Health Care Services

12 Jun 2023

Investment Date

£ 96 M

Deal Value

beacon therapeutics (contract, manufacturing and controls team)

HQ - United States

Biotechnology

9 Apr 2024

Investment Date

100%

Stake

n/a

Deal Value

beacon therapeutics limited

HQ - United States

Health Care Services

3 Jul 2024

Investment Date

£ 134 M

Deal Value

beacon therapeutics limited

HQ - United States

Biotechnology

8 Jan 2026

Investment Date

£ 55 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy